Timber Hill’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-179,300
Closed -$12.2M 1266
2017
Q1
$12.2M Sell
179,300
-77,900
-30% -$5.48M 0.09% 162
2016
Q4
$18.4M Sell
257,200
-59,800
-19% -$4.44M 0.08% 187
2016
Q3
$25.1M Sell
317,000
-49,700
-14% -$4.04M 0.12% 138
2016
Q2
$30.6M Sell
366,700
-47,700
-12% -$4.23M 0.14% 125
2016
Q1
$38.1M Buy
414,400
+157,200
+61% +$14.2M 0.18% 88
2015
Q4
$26M Sell
257,200
-199,000
-44% -$20.7M 0.13% 116
2015
Q3
$44.8M Buy
456,200
+10,500
+2% +$1.17M 0.19% 94
2015
Q2
$52.2M Buy
445,700
+2,300
+0.5% +$251K 0.23% 62
2015
Q1
$43.5M Buy
443,400
+60,700
+16% +$6.16M 0.2% 90
2014
Q4
$36.1M Sell
382,700
-26,700
-7% -$2.76M 0.15% 104
2014
Q3
$43.6M Sell
409,400
-80,600
-16% -$7.89M 0.18% 73
2014
Q2
$40.6M Buy
490,000
+88,100
+22% +$6.86M 0.18% 67
2014
Q1
$28.5M Buy
401,900
+220,300
+121% +$17.3M 0.12% 138
2013
Q4
$13.6M Sell
181,600
-28,400
-14% -$1.98M 0.05% 320
2013
Q3
$13.2M Sell
210,000
-152,700
-42% -$9.13M 0.05% 339
2013
Q2
$18.6M Buy
+362,700
New +$18.9M 0.07% 236

Other funds holding GILD

Timber Hill's GILD Position: Q2 2018 in Review

Timber Hill sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 44,893 shares — an estimated $3.38M sold.

Timber Hill first reported a position in GILD in Q3 2013 and held it in 11 quarters. The position peaked at $5.78M in Q3 2013. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Timber Hill reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Timber Hill sold 44,893 Gilead Sciences shares in Q2 2018, an estimated $3.38M.
  • Timber Hill first reported a position in Gilead Sciences in Q3 2013 and held it in 11 quarters.
  • Timber Hill's Gilead Sciences position peaked at $5.78M in Q3 2013.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.